Camels the Link to MERS?

A Middle East Respiratory Syndrome patient’s pet camel tests positive for the coronavirus.

Written byAbby Olena, PhD
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, SALLYSEASHELLSIn Saudi Arabia, two new cases of Middle East Respiratory Syndrome (MERS) were confirmed this month, according to the World Health Organization (WHO). These cases bring the global total of MERS infections to 153, including 64 deaths. The source of MERS is still unknown, though some evidence points to bats as the original source of the virus and camels as the intermediate between bats and humans. Antibodies to MERS have been previously found in camels, but until now, no camels had been found carrying the virus.

This week, a pet camel belonging to one of the new MERS cases in Saudi Arabia has tested positive for the coronavirus. According to BBC News, the Saudi government said in a statement that it is working to assess whether the viral strain from the camel matches the strain found in the human patient. If they “prove to be identical, this would be a first scientific discovery worldwide, and a door to identify the source of the virus,” the Saudi Health Ministry said.

Scientists believe that finding and confirming the animal reservoir of MERS is important to eradicating it. “If we know that, there’s a possibility we can stop it, like H7N9 and SARS—you close the animal markets, the risk goes away,” microbiologist and physician ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies